QJM Advance Access originally published online on July 29, 2008
QJM 2008 101(9):749-751; doi:10.1093/qjmed/hcn082
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting
| The first 10% of the full text of this article appears below. |
Sir,
We read with great interest the excellent review by Foley et al. who evaluate the risks of gastrointestinal bleeding in patients undergoing percutaneous coronary intervention (PCI) in relation to anti-platelet therapy.1 The authors emphasize the importance of several gastrointestinal bleeding major risk factors including use of dual anti-platelet therapy or non-steroidal anti-inflammatory drugs, increasing age, previous ulceration, helicobacter pylori infection, use of non-steroidal anti-inflammatory
Department of Cardiology, Hospital Universitario
Virgen de la Arrixaca, Murcia, Spain
Department of Cardiology, Hospital General
Universitario de Alicante, Spain
University Department of Medicine, City Hospital,
Birmingham (UK)
email: g.y.h.lip@bham.ac.uk